The 2024 IAS–USA HIV Treatment and Prevention Guidelines are Now Published

Today, on World AIDS Day, December 1, 2024, the Journal of the American Medical Association (JAMA) released the newly updated Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel.

The IAS–USA HIV Treatment and Prevention Guidelines are freely accessible on the JAMA website by subscription or signing up for a free account: https://jamanetwork.com/journals/jama/fullarticle/2827545

For an exclusive brief review of these highly anticipated updates, join us on December 3 for the Annual IAS-USA Washington, DC Virtual Course: Update on HIV Medicine Emerging Challenges. Other key topics include strategies to reduce cardiovascular disease risk in people with HIV; the potential use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to treat addiction; guidelines on screening for and treatment of human papillomavirus (HPV)-related cancers; and the implementation of long-acting drugs for HIV treatment and prevention.

For a comprehensive overview of the key changes and updates to the guidelines, please join us for a virtual course on December 12, the 2024 IAS-USA Guidelines Virtual Update: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults. Participation is free and open to all.